Sartorius Stedim Biotech SA
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
04-Aug-2026 / 10:11 CET/CEST
Dissemination of a French Regulatory News, transmitted by .
The issuer is solely responsible for the content of this announcement.
Sartorius Stedim Biotech S.A. - 13400 Aubagne, France
DECLARATION RELATIVE TO
THE NUMBER OF SHARES AND VOTING RIGHTS
MAKING UP THE ISSUED CAPITAL
Article L 233-8-II of the Code of commerce
and article 223-6 of the general regulations of the AMF
Designation of issuer
SARTORIUS STEDIM BIOTECH SA
CS 91051
Z. I. Les Paluds
Avenue de Jouques
13400 Aubagne
Date of information July 31, 2026 | Total number of shares making up the issued capital 97,330,405 | Total number of theoretical voting rights including treasury shares 164,770,933 | Total number of net voting rights 164,721,373 |
| Language:English | Company:Sartorius Stedim Biotech SA | Avenue de Jouques | 13781 Aubagne | France | Phone:+33 44 284 5600 | E-mail:[email protected] | Internet:www.sartorius.com | ISIN:FR0013154002 | Euronext Ticker:DIM | AMF Category:Total number of voting rights and share capital / Information on the total number of voting rights and the number of shares making up the share capital | EQS News ID:2376946 |
| End of AnnouncementEQS News Service |
2376946 04-Aug-2026 CET/CEST
Saving the news in databases or any forwarding of the news to third parties in a commercial context or for commercial purposes is only permitted with the prior written consent of EQS Group AG.